Form 8-K - Current report:
SEC Accession No. 0001628280-25-012022
Filing Date
2025-03-11
Accepted
2025-03-11 16:32:41
Documents
15
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20250311.htm   iXBRL 8-K 35263
2 EX-99.1 csbr8-k1312025ex991xq325.htm EX-99.1 178950
6 logobranding_headerleftalia.jpg GRAPHIC 32167
  Complete submission text file 0001628280-25-012022.txt   382478

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20250311.xsd EX-101.SCH 1813
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20250311_lab.xml EX-101.LAB 19154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20250311_pre.xml EX-101.PRE 10996
17 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20250311_htm.xml XML 2446
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 25728111
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)